Janice D. Smith

Southampton, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 44 publications

Tolerability, dose modification, and treatment compliance with adjuvant abemaciclib in high-risk early breast cancer: a UK real-world multicentre study (CONCISE).

Tolerability, dose modification, and treatment compliance with adjuvant abemaciclib in high-risk early breast cancer: a UK real-world multicentre study (CONCISE).

Journal: ESMO real world data and digital oncology
Published: September 05, 2026

National TB cohort review evaluation: insights for control strategies in low-incidence settings.

National TB cohort review evaluation: insights for control strategies in low-incidence settings.

Journal: IJTLD open
Published: February 11, 2026

The Regulatory Interplay of the Colorectal Cancer Biomarkers MACC1 and IER2 and Its Impact on Metastatic Cancer Survival.

The Regulatory Interplay of the Colorectal Cancer Biomarkers MACC1 and IER2 and Its Impact on Metastatic Cancer Survival.

Journal: Biomolecules
Published: November 11, 2025

Opening the operating theatre to oncology: treatment of locally recurrent rectal cancer with peritoneal metastasis by simultaneous hyperthermic intraperitoneal chemotherapy and intraoperative electron beam radiotherapy.

Opening the operating theatre to oncology: treatment of locally recurrent rectal cancer with peritoneal metastasis by simultaneous hyperthermic intraperitoneal chemotherapy and intraoperative electron beam radiotherapy.

Journal: Annals of the Royal College of Surgeons of England
Published: June 11, 2025

Safety and Efficacy of Atezolizumab in Combination With nab-Paclitaxel in Patients With PD-L1 Positive Metastatic or Locally Advanced Triple-Negative Breast Cancer: A UK-Wide Cancer Centre Experience.

Safety and Efficacy of Atezolizumab in Combination With nab-Paclitaxel in Patients With PD-L1 Positive Metastatic or Locally Advanced Triple-Negative Breast Cancer: A UK-Wide Cancer Centre Experience.

Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: April 11, 2025

Induction of circulating ABCB1 transcripts under platinum-based chemotherapy indicates poor prognosis and a bone micrometastatic phenotype in ovarian cancer patients.

Induction of circulating ABCB1 transcripts under platinum-based chemotherapy indicates poor prognosis and a bone micrometastatic phenotype in ovarian cancer patients.

Journal: Molecular cancer
Published: June 28, 2024

Multiple endocrine neoplasia type 2A syndrome presenting with corneal nerve thickening.

Multiple endocrine neoplasia type 2A syndrome presenting with corneal nerve thickening.

Journal: QJM : monthly journal of the Association of Physicians
Published: November 06, 2023

GIPC1 regulates MACC1-driven metastasis.

GIPC1 regulates MACC1-driven metastasis.

Journal: Frontiers in oncology
Published: August 21, 2023

Cantharidin and Its Analogue Norcantharidin Inhibit Metastasis-Inducing Genes S100A4 and MACC1.

Cantharidin and Its Analogue Norcantharidin Inhibit Metastasis-Inducing Genes S100A4 and MACC1.

Journal: International journal of molecular sciences
Published: November 08, 2022

MACC1-Dependent Antitumor Effect of Curcumin in Colorectal Cancer.

MACC1-Dependent Antitumor Effect of Curcumin in Colorectal Cancer.

Journal: Nutrients
Published: October 11, 2022

The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis.

The newly identified MEK1 tyrosine phosphorylation target MACC1 is druggable by approved MEK1 inhibitors to restrict colorectal cancer metastasis.

Journal: Oncogene
Published: January 27, 2021

Saffron Crudes and Compounds Restrict MACC1-Dependent Cell Proliferation and Migration of Colorectal Cancer Cells.

Saffron Crudes and Compounds Restrict MACC1-Dependent Cell Proliferation and Migration of Colorectal Cancer Cells.

Journal: Cells
Published: June 29, 2020
Showing 1-12 of 44

Last Updated: 09/26/2026